Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Guidance on JAK inhibitor treatment for inborn errors of JAK-STAT signaling (2026). An international consensus statement on behalf of the ESID/EBMT-IEWP and ERN-RITA.

The Journal of allergy and clinical immunology·2026
Same author

[Clinicopathological features of primary mucosal CD30-positive T-cell lymphoproliferative disorders].

Zhonghua bing li xue za zhi = Chinese journal of pathology·2024
Same author

[Influence of family with sequence similarity 134, member B-mediated reticulophagy on lipopolysaccharide-induced apoptosis of mouse dendritic cells].

Zhonghua shao shang yu chuang mian xiu fu za zhi·2023
Same author

[Topography-guided transepithelial corneal collagen cross-linking by sequential ultraviolet A irradiation in different diameters for progressive keratoconus in adults].

[Zhonghua yan ke za zhi] Chinese journal of ophthalmology·2023
Same author

Effects of oleanolic acid on acute liver injury triggered by lipopolysaccharide in broiler chickens.

British poultry science·2023
Same author

[Autophagy regulates multiple organ injury in obstructive sleep apnea and its related mechanisms].

Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases·2023

Related Experiment Video

Updated: May 8, 2026

Development and Optimization of A Human Hepatocellular Carcinoma Patient-Derived Organoid Model for Potential Target Identification and Drug Discovery
07:25

Development and Optimization of A Human Hepatocellular Carcinoma Patient-Derived Organoid Model for Potential Target Identification and Drug Discovery

Published on: August 18, 2023

HCC patients suffer less from geographic differences in organ availability.

C Schuetz1, N Dong, E Smoot

  • 1Department of Surgery, Division of Transplantation, Massachusetts General Hospital, Boston, MA.

American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons
|September 10, 2013
PubMed
Summary

The Model for End-Stage Liver Disease (MELD) exception points for hepatocellular carcinoma (HCC) may overestimate mortality risk. HCC patients face lower waitlist mortality compared to non-HCC patients, especially with increased organ competition.

Keywords:
Hepatocellular carcinomaMELD scoredonation service arealiver transplantationorgan allocation

More Related Videos

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

A Hepatocellular Cancer Patient-Derived Organoid Xenograft Model to Investigate Impact of Liver Regeneration on Tumor Growth
08:15

A Hepatocellular Cancer Patient-Derived Organoid Xenograft Model to Investigate Impact of Liver Regeneration on Tumor Growth

Published on: February 2, 2024

Related Experiment Videos

Last Updated: May 8, 2026

Development and Optimization of A Human Hepatocellular Carcinoma Patient-Derived Organoid Model for Potential Target Identification and Drug Discovery
07:25

Development and Optimization of A Human Hepatocellular Carcinoma Patient-Derived Organoid Model for Potential Target Identification and Drug Discovery

Published on: August 18, 2023

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

A Hepatocellular Cancer Patient-Derived Organoid Xenograft Model to Investigate Impact of Liver Regeneration on Tumor Growth
08:15

A Hepatocellular Cancer Patient-Derived Organoid Xenograft Model to Investigate Impact of Liver Regeneration on Tumor Growth

Published on: February 2, 2024

Area of Science:

  • Hepatology
  • Transplant Surgery
  • Biostatistics

Background:

  • The Model for End-Stage Liver Disease (MELD) exception points for hepatocellular carcinoma (HCC) may overestimate patient mortality risk.
  • Organ availability, measured by average MELD at transplant, varies by donation service area (DSA) and impacts transplant outcomes.
  • Understanding differential impacts of DSA organ availability on HCC and non-HCC patients is crucial for equitable organ allocation.

Purpose of the Study:

  • To compare transplant and death parameters between HCC patients with exception points and non-HCC patients.
  • To determine if HCC and non-HCC groups are differentially affected by DSA organ availability.
  • To assess the accuracy of MELD exception points in reflecting actual mortality risk.

Main Methods:

  • Analysis of Scientific Registry of Transplant Recipients data from 2005 to 2010.
  • Comparison of transplant rates and waitlist mortality between HCC and non-HCC patient cohorts.
  • Statistical analysis of the relationship between MELD scores, DSA, and mortality risk pre- and post-transplant.

Main Results:

  • HCC candidates exhibit higher transplant rates and lower waitlist mortality than non-HCC candidates.
  • Waitlist mortality risk decreases for HCC patients with increasing MELD points (not statistically significant), but increases significantly for non-HCC patients.
  • Post-transplant mortality risk decreases with MELD points for HCC patients (not statistically significant) but increases for non-HCC patients, with significant differences between groups.

Conclusions:

  • Increasing wait time disproportionately affects non-HCC candidates compared to HCC candidates.
  • The MELD exception system may confer an advantage to HCC patients, particularly under conditions of high organ competition.
  • Further research is needed to refine MELD scoring to ensure equitable organ allocation.